Orgenesis Inc. Stock
Stocks
ORGS
US68619K3032
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Delayed
OTC Markets
22:04:45 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0280 USD | -39.94% |
|
-92.98% | -81.27% |
| 03-26 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| 03-26 | Orgenesis Inc. Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 985K 882K 812K 735K 1.37M 93.55M 1.4M 9.68M 3.89M 49.21M 3.7M 3.62M 155M | P/E 2023 |
-0.26x | P/E 2024 | -0.17x |
|---|---|---|---|---|---|
| Enterprise Value | 19.17M 17.17M 15.79M 14.31M 26.74M 1.82B 27.24M 188M 75.59M 957M 71.93M 70.4M 3.02B | EV / Sales 2023 |
71.2x | EV / Sales 2024 | 27x |
| Free-Float |
52.06% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -39.94% | ||
| 1 week | -92.98% | ||
| Current month | +0.18% | ||
| 1 month | -94.89% | ||
| 3 months | -96.04% | ||
| 6 months | -92.98% | ||
| Current year | -81.27% |
| 1 week | 0 |  | 0.4 |
| 1 month | 0 | | 0.55 |
| Current year | 0 | | 0.84 |
| 1 year | 0 | | 0.91 |
| 3 years | 0 | | 10.8 |
| 5 years | 0 | | 52 |
| 10 years | 0 | | 168 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Ferber
CTO | Chief Tech/Sci/R&D Officer | 72 | 02/02/2012 |
Vered Caplan
CEO | Chief Executive Officer | 57 | 24/12/2013 |
Douglas Karriker
DFI | Director of Finance/CFO | 51 | 10/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Vered Caplan
CHM | Chairman | 57 | 14/08/2014 |
Itzhak Vider
BRD | Director/Board Member | 64 | 08/07/2024 |
Adam Pelavin
BRD | Director/Board Member | 47 | 28/10/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/5/25 A | Other | 1,200,000 | 23.2142% | |||
| 12/12/24 A | Free | Director | 1,500 | 0.0290% | ||
| 12/12/24 A | Free | Director | 1,835 | 0.0355% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -39.94% | -92.98% | -81.27% | -99.65% | 275K | |
| +2.02% | +2.02% | -13.60% | +11.50% | 184B | |
| +0.69% | +2.44% | +7.66% | +34.70% | 118B | |
| +1.86% | -3.85% | -17.82% | +5.79% | 111B | |
| +0.90% | +6.37% | -41.28% | +6.02% | 94.58B | |
| -0.14% | +0.29% | -2.93% | +72.21% | 63.13B | |
| -5.48% | -5.11% | -1.45% | +61.88% | 55.66B | |
| -0.05% | +1.06% | +11.94% | -22.45% | 53.9B | |
| +18.98% | +9.61% | -13.55% | +49.01% | 43.42B | |
| +0.91% | +1.90% | +0.17% | -10.38% | 34.68B | |
| Average | -2.04% | -9.25% | -15.21% | +10.86% | 75.84B | |
| Weighted average by Cap. | +1.68% | +0.24% | -10.13% | +21.08% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 530K 475K 437K 396K 739K 50.32M 753K 5.21M 2.09M 26.47M 1.99M 1.95M 83.48M | 1.03M 927K 853K 773K 1.44M 98.27M 1.47M 10.17M 4.08M 51.69M 3.88M 3.8M 163M |
| Net income | -55.36M -49.58M -45.61M -41.32M -77.24M -5.26B -78.69M -544M -218M -2.77B -208M -203M -8.72B | -48.16M -43.14M -39.68M -35.95M -67.2M -4.57B -68.46M -473M -190M -2.41B -181M -177M -7.59B |
| Net Debt | 21.78M 19.51M 17.95M 16.26M 30.39M 2.07B 30.96M 214M 85.91M 1.09B 81.75M 80.01M 3.43B | 18.18M 16.28M 14.98M 13.57M 25.37M 1.73B 25.84M 179M 71.7M 908M 68.23M 66.78M 2.86B |
Employees
77
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | $0.0281 | -39.94% | 6,300 |
| 27/10/26 | $0.0467 | -86.66% | 2,611 |
- Stock Market
- Stocks
- ORGS Stock
Select your edition
All financial news and data tailored to specific country editions
